Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study

Detalles Bibliográficos
Autores principales: Reville, Patrick K., Kantarjian, Hagop M., Ravandi, Farhad, Jabbour, Elias, DiNardo, Courtney D., Daver, Naval, Pemmaraju, Naveen, Ohanian, Maro, Alvarado, Yesid, Xiao, Lianchun, Alatrash, Gheath, Loghavi, Sanam, Rausch, Caitlin R., Borthakur, Gautam, Konopleva, Marina, Cortes, Jorge, Kadia, Tapan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969746/
https://www.ncbi.nlm.nih.gov/pubmed/33731681
http://dx.doi.org/10.1038/s41408-021-00453-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969746/
https://www.ncbi.nlm.nih.gov/pubmed/33731681
http://dx.doi.org/10.1038/s41408-021-00453-z

Ejemplares similares